Search Results
Jun 01, 2026, 09:40 ET Escape into Endless Summer with dōTERRA's New Seasonal Collection
Endless Summer Sunshine Blend + Pilot Diffuser Bundle pairs the 15 mL blend with dōTERRA's compact, rechargeable diffuser designed for life on the move. Offering up to four hours of continuous or eight hours of intermittent
More news about: doTERRA International, LLC
Jun 01, 2026, 09:30 ET ZPE Systems Introduces NSR 2U and NVIDIA Jetson Expansion Card, Combining AI Acceleration, Networking, and Infrastructure Resilience
GPU‑powered intelligence directly into the Nodegrid ecosystem. Designed for both the NSR and NSR 2U platforms, this card enables customers to run AI/ML workloads where they matter most: close to data sources, users, and critical infrastructure.This new module allows organizations to:Run
More news about: Legrand DPC LLC
Jun 01, 2026, 09:05 ET Everest Group Names Nividous a Major Contender for the Sixth Consecutive Year in IDP Products PEAK Matrix® Assessment 2026
Delivers end-to-end intelligent automation across RPA, Generative AI, Agentic AI, Low-Code Process Automation, and IDP, combining NLP, AI/ML, OCR, and computer vision to process semi-structured and unstructured documents.Supports extraction from all major input data types, including
More news about: Nividous
Jun 01, 2026, 08:34 ET Paradyne AI, a Next Generation AI company, Led by Decorated U.S. Special Operations AI Architect to open in Las Vegas, Nevada
discrete commercial applications, today announced its launch from Las Vegas, Nevada. The company is led by Alam Anthony Jamal, one of the most decorated AI/ML integration architects in U.S. Special Operations and an inventor of multiple AI-enabled computer vision and sensor fusion capabilities. Jamal's
More news about: Paradyne AI
Jun 01, 2026, 08:31 ET Niobium Opens Developer Partner Program for The Fog, the First IaaS Purpose-Built for Fully Homomorphic Encryption
patient records, genomic data, or medical images across institutions without exposing individual records, making multi-party collaboration and cloud-based ML analysis on sensitive clinical data technically viable for the first time. Financial institutions can pool fraud
More news about: Niobium
Jun 01, 2026, 08:30 ET Sidus Space Expected Russell Index Inclusion Reflects Continued Execution of Growth and Commercialization Strategy
solutions, including satellite manufacturing and technology integration, AI-driven space-based data solutions, mission planning and management operations, AI/ML products and services, and space and defense hardware manufacturing. With its mission of Space Access Reimagined®, Sidus Space is committed to rapid
More news about: Sidus Space, Inc.
Jun 01, 2026, 08:04 ET Hennessy Very Special Cocktails: A New Ready-to-Serve Hennessy Launch in the U.S. This June
meaning, connection and celebration.The Hennessy Very Special Cocktails collection features three distinctive recipes packaged in convenient 375 ml Hennessy Very Special bottles:Henny-Rita (18% ABV): A refreshing and vibrant twist on a timeless favorite. Henny-Rita
More news about: Hennessy
Jun 01, 2026, 08:00 ET PKWARE Re-Engineers Key Management for Continuous Cryptographic Change
content, endpoint, server, SharePoint, and mainframe, all protected through a single architecture.Full NIST PQC suite supported. ML-KEM, ML-DSA, SLH-DSA. CNSA 2.0 aligned.Hybrid classical and PQC encryption by default. Legacy and quantum-capable systems decrypt the same file.
More news about: PKWARE, Inc.
Jun 01, 2026, 06:30 ET VIAVI Introduces GNSS-Disciplined Oscillator for Precision Timing in Size, Weight and Power-Constrained Platforms
platforms, time appliance cards and embedded systems without custom mechanical design, all while drawing approximately half a wattPatented AI and ML algorithms developed by the Jackson Labs team, now part of VIAVI, predict and compensate for oscillator behavior across environmental conditionsThe
More news about: VIAVI Solutions
Jun 01, 2026, 06:30 ET GPU Server Market to Reach USD 1,545.2 billion by 2033 Amid AI Boom - Grand View Research, Inc.
billion by 2033, growing at a CAGR of 35.8% from 2025 to 2033 due to the rapid adoption of artificial intelligence (AI), machine learning (ML), and deep learning applications across industries.The Data Center GPU Market is emerging as a critical segment within the broader GPU ecosystem,
More news about: Grand View Research, Inc.
Jun 01, 2026, 03:15 ET No. 1 on Amazon Germany: COSRX Ultra-Light Invisible Sunscreen SPF50+ PA++++ Tops the German Market
without Oxybenzone and Octinoxate.Product FactsProduct: COSRX Ultra-Light Invisible Sunscreen SPF50+Size: 50 mlSun Protection: SPF50+ PA++++Key Ingredients: Aloe Vera Leaf Water (66.4%), Witch Hazel, Vitamin E, Hyaluronic Acid, Allantoin, Niacinamide,
More news about: COSRX
Jun 01, 2026, 03:15 ET Nr. 1 auf Amazon Deutschland: COSRX Ultra-Light Invisible Sunscreen SPF50+ PA++++ führt den deutschen Markt an
Octinoxat formuliert.Fakten zum ProduktProdukt: COSRX Ultra-Light Invisible Sunscreen SPF50+Größe: 50 mlSonnenschutz: SPF50+ PA++++Hauptinhaltsstoffe: Aloe-Vera-Blattwasser (66,4%), Hamamelis, Vitamin E, Hyaluronsäure, Allantoin, Niacinamid,
More news about: COSRX
Jun 01, 2026, 03:15 ET Numéro 1 sur Amazon Allemagne : l'écran solaire invisible ultraléger SPF50+ PA++++ de COSRX en tête du marché allemand
octinoxate.Caractéristiques du produitNom du produit : écran solaire invisible ultraléger SPF50+ de COSRXContenance : 50 mlProtection solaire : SPF50+ PA++++Principaux ingrédients : eau de feuilles d'Aloe vera (66,4 %), hamamélis, vitamine E, acide hyaluronique,
More news about: COSRX
May 31, 2026, 23:51 ET Aphranel® MagiCCrystal CaHA Filler obtient la certification MDR de l'UE en tant qu'injectable régénérateur de première qualité
gamme, Aphranel se positionne comme un produit injectable régénérateur haut de gamme, avec un prix de vente recommandé de 12 800 RMB par seringue de 0,5 ml.Aphranel a également introduit le concept de « Poétique du temps », qui reflète son intérêt pour l'esthétique régénératrice, l'amélioration progressive
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 31, 2026, 23:50 ET Aphranel® MagiCCrystal CaHA Filler erhält die EU MDR-Zertifizierung als hochwertiges regeneratives Injektionsmittel
Ästhetik ist Aphranel als regeneratives injizierbares Produkt der Spitzenklasse positioniert, mit einem empfohlenen Verkaufspreis von 12.800 RMB pro 0,5-mL-Spritze.Aphranel hat auch das Konzept der „Poetik der Zeit" eingeführt, das den Schwerpunkt auf regenerative Ästhetik, schrittweise Verbesserung
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 31, 2026, 22:37 ET ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential
(PR), with target lesions shrinking by 96.1% (from 155.45 mm to 6 mm) and alpha-fetoprotein (AFP) levels plummeting by 99.1% (from >80,000 ng/mL to 742 ng/mL). The patient achieved an overall survival (OS) of nearly three years.
More news about: Oricell Therapeutics Holdings Limited
May 31, 2026, 08:01 ET Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
dosage modification is recommended for patients with mild to severe renal impairment (estimated Glomerular Filtration Rate [eGFR] ≥15 to 89 mL/min, estimated by Modification of Diet in Renal Disease [MDRD] equation). A recommended dosage has not been established for patients with end-stage renal
More news about: Eli Lilly and Company
May 29, 2026, 16:01 ET Sidus Space Announces Closing of Offering
solutions, including satellite manufacturing and technology integration, AI-driven space-based data solutions, mission planning and management operations, AI/ML products and services, and space and defense hardware manufacturing. With its mission of Space Access Reimagined®, Sidus Space is committed to rapid
More news about: Sidus Space, Inc.
May 29, 2026, 14:00 ET RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
GILOTRIF® (afatinib tablets), for oral use [package insert]. Boehringer Ingelheim Pharmaceuticals, Inc.; 2022. 8 Moores SL, Chiu ML, Bushey BS, et al. A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung Tumors. Cancer Res. 2016;76(13):3942-3953.
More news about: Johnson & Johnson
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
renal function (CrCl <80 mL/min) may require more intensive prophylaxis and monitoring to reduce the risk of TLS at initiation and during the dose-titration phase. Venetoclax should be administered to patients with severe renal impairment (CrCl ≥15 ml/min and <30 ml/min) or end-stage renal disease
More news about: AbbVie
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
renal function (CrCl <80 mL/min) may require more intensive prophylaxis and monitoring to reduce the risk of TLS at initiation and during the dose-titration phase. Venetoclax should be administered to patients with severe renal impairment (CrCl ≥15 ml/min and <30 ml/min) or end-stage renal disease
More news about: AbbVie
May 29, 2026, 07:00 ET Alaw Therapeutics Announces Two Major Pipeline Milestones Advancing Brain-Penetrant CDK Oncology Programs
development, as well as RIPTAC therapeutic programs designed for programmable tumor-selective pathway control. Alaw integrates advanced medicinal chemistry, AI/ML-enabled discovery technologies, and translational biology to develop differentiated therapies for aggressive and resistant cancers.For more information,
More news about: Alaw Therapeutics
May 29, 2026, 02:28 ET Aphranel® MagiCCrystal obtiene la certificación EU MDR
gama, Aphranel se posiciona como un producto inyectable regenerativo de alta gama, con un precio de venta recomendado de 12.800 RMB por jeringa de 0,5 ml.Aphranel también ha introducido el concepto de "La Poética del Tiempo", que refleja su enfoque en la estética regenerativa, la mejora gradual y
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 28, 2026, 19:10 ET FDA approves label expansion, cementing TREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage
1-800-FDA-1088.Dosage Forms and Strengths: TREMFYA® is available as 100 mg/mL and 200 mg/2mL for subcutaneous injection and as a 200 mg/20 mL (10 mg/mL) single dose vial for intravenous infusion.ABOUT JOHNSON & JOHNSONAt Johnson & Johnson,
More news about: Johnson & Johnson
May 28, 2026, 16:05 ET MongoDB, Inc. Announces First Quarter Fiscal 2027 Financial Results
guidance or other expectations about our business and future operating results; reputational harm or other adverse consequences resulting from use of AI and ML in our product offerings and internal operations if they don't produce the desired benefits; our limited operating history; our history of losses; our
More news about: MongoDB, Inc.